Vanda Pharmaceuticals (VNDA) EBITDA Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,659.00 |
| Dec 31, 2025 | -1,492.00 |
| Sep 30, 2025 | 1,763.00 |
| Jun 30, 2025 | 882.00 |
| Mar 31, 2025 | -6,269.00 |
| Dec 31, 2024 | 380.00 |
| Sep 30, 2024 | -296.00 |
| Jun 30, 2024 | -65.00 |
| Mar 31, 2024 | -381.00 |
| Dec 31, 2023 | -29.00 |
| Sep 30, 2023 | -919.00 |
| Jun 30, 2023 | -941.00 |
| Mar 31, 2023 | -702.00 |
| Dec 31, 2022 | 425.00 |
| Sep 30, 2022 | 58.00 |
| Jun 30, 2022 | 1,806.00 |
| Mar 31, 2022 | -2,545.00 |
| Dec 31, 2021 | -267.00 |
| Sep 30, 2021 | -280.00 |
| Jun 30, 2021 | 167.00 |
| Mar 31, 2021 | 108.00 |
| Dec 31, 2020 | 256.00 |
| Sep 30, 2020 | -188.00 |
| Jun 30, 2020 | 1,490.00 |
| Mar 31, 2020 | -719.00 |
| Dec 31, 2019 | -1,109.00 |
| Sep 30, 2019 | 135.00 |
| Jun 30, 2019 | 2,101.00 |
| Mar 31, 2019 | -2,163.00 |
| Dec 31, 2018 | 455.00 |
| Sep 30, 2018 | 438.00 |
| Jun 30, 2018 | 262.00 |
| Mar 31, 2018 | 1,057.00 |
| Dec 31, 2017 | 692.00 |
| Sep 30, 2017 | -651.00 |
| Jun 30, 2017 | 1,656.00 |
| Mar 31, 2017 | -1,942.00 |
| Dec 31, 2016 | -1.00 |
| Sep 30, 2016 | 1,160.00 |
| Jun 30, 2016 | 2,421.00 |
| Mar 31, 2016 | 926.00 |
| Dec 31, 2015 | -1,310.00 |
| Sep 30, 2015 | -1,387.00 |
| Jun 30, 2015 | 2,668.00 |
| Mar 31, 2015 | -49,990.00 |
| Dec 31, 2014 | 46,323.00 |
| Sep 30, 2014 | 18,912.00 |
| Jun 30, 2014 | 9,178.00 |
| Mar 31, 2014 | -20,199.00 |
| Dec 31, 2013 | -2,634.00 |
| Sep 30, 2013 | -2,133.00 |
| Jun 30, 2013 | 1,555.00 |
| Mar 31, 2013 | 2,458.00 |
| Dec 31, 2012 | -1,607.00 |
| Sep 30, 2012 | 3,141.00 |
| Jun 30, 2012 | 566.00 |
| Mar 31, 2012 | -3,158.00 |
| Dec 31, 2011 | -2,926.00 |
| Sep 30, 2011 | -2,096.00 |
| Jun 30, 2011 | -2,046.00 |
| Mar 31, 2011 | 1,657.00 |
| Dec 31, 2010 | -2,673.00 |
| Sep 30, 2010 | -6,478.00 |